These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11290547)

  • 41. The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-x(L) protein.
    Bhonde MR; Hanski ML; Magrini R; Moorthy D; Müller A; Sausville EA; Kohno K; Wiegand P; Daniel PT; Zeitz M; Hanski C
    Oncogene; 2005 Jan; 24(1):148-56. PubMed ID: 15467762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis.
    España L; Fernández Y; Rubio N; Torregrosa A; Blanco J; Sierra A
    Breast Cancer Res Treat; 2004 Sep; 87(1):33-44. PubMed ID: 15377849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2.
    Wilkins HR; Doucet K; Duke V; Morra A; Johnson N
    Tumour Biol; 2010 Jan; 31(1):16-22. PubMed ID: 20237898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pax9 mediated cell survival in oral squamous carcinoma cell enhanced by c-myb.
    Lee JC; Sharma M; Lee YH; Lee NH; Kim SY; Yun JS; Nam SY; Hwang PH; Jhee EC; Yi HK
    Cell Biochem Funct; 2008 Dec; 26(8):892-9. PubMed ID: 18979497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells.
    Corradini F; Bussolari R; Cerioli D; Lidonnici MR; Calabretta B
    Blood Cells Mol Dis; 2007; 39(3):292-6. PubMed ID: 17644012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A correlation analysis of miRNA‑34a and its predicted target genes in leukemia.
    Tang R; Li J; Yue M; Liu Z; Feng S; Tang S; Wang T
    Mol Med Rep; 2014 Apr; 9(4):1283-8. PubMed ID: 24504520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RSL3 enhances ROS-mediated cell apoptosis of myelodysplastic syndrome cells through MYB/Bcl-2 signaling pathway.
    Liu L; Yang C; Zhu L; Wang Y; Zheng F; Liang L; Cao P; Liu J; Han X; Zhang J
    Cell Death Dis; 2024 Jul; 15(7):465. PubMed ID: 38956026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression and clinical significances of c-myb and Bax proteins in endometrial carcinoma].
    Feng YK; Lu L; Zhang YQ; He L; Lin W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):797-800. PubMed ID: 25341343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The expression of the apoptosis-suppressive gene bcl-2 in the tissue of colon carcinoma.
    Huang W; Yao X
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(3):218-20. PubMed ID: 12658808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb.
    Kumar A; Baker SJ; Lee CM; Reddy EP
    Mol Cell Biol; 2003 Sep; 23(18):6631-45. PubMed ID: 12944488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A supervised network analysis on gene expression profiles of breast tumors predicts a 41-gene prognostic signature of the transcription factor MYB across molecular subtypes.
    Liu LY; Chang LY; Kuo WH; Hwa HL; Chang KJ; Hsieh FJ
    Comput Math Methods Med; 2014; 2014():813067. PubMed ID: 24639887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High c-Myb Expression Associates with Good Prognosis in Colorectal Carcinoma.
    Tichý M; Knopfová L; Jarkovský J; Vlček P; Katolická J; Čapov I; Hermanová M; Šmarda J; Beneš P
    J Cancer; 2019; 10(6):1393-1397. PubMed ID: 31031849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MYB-QKI drives childhood brain tumors via tripartite mechanism.
    Jain P; Resnick AC
    Cell Cycle; 2017 Mar; 16(5):390-391. PubMed ID: 27973981
    [No Abstract]   [Full Text] [Related]  

  • 55. Polymorphous sweat gland carcinoma found to have MYB rearrangement.
    Hafeez F; Xiao S; Dal Cin P; Krane JF; Chen P; Hayek J; Lian CG
    Histopathology; 2020 Apr; 76(5):779-781. PubMed ID: 31667857
    [No Abstract]   [Full Text] [Related]  

  • 56. Reply: Comment on 'Association of sedentary behaviour with colon and rectal cancer: a meta-analysis of observational studies'.
    Lu Z; Cao S; Gan Y; Cong Y
    Br J Cancer; 2014 Nov; 111(11):2203. PubMed ID: 24569465
    [No Abstract]   [Full Text] [Related]  

  • 57. Distinguishing sedentary from inactive: implications for meta-analyses.
    Lynch BM; Boyle T
    Br J Cancer; 2014 Nov; 111(11):2202-3. PubMed ID: 24569462
    [No Abstract]   [Full Text] [Related]  

  • 58. Intestinal-specific activatable Myb initiates colon tumorigenesis in mice.
    Malaterre J; Pereira L; Putoczki T; Millen R; Paquet-Fifield S; Germann M; Liu J; Cheasley D; Sampurno S; Stacker SA; Achen MG; Ward RL; Waring P; Mantamadiotis T; Ernst M; Ramsay RG
    Oncogene; 2016 May; 35(19):2475-84. PubMed ID: 26300002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Situational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis.
    George OL; Ness SA
    Cancers (Basel); 2014 Oct; 6(4):2049-71. PubMed ID: 25279451
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.